Research programme: diabetes therapy - Digital Gene Technologies

Drug Profile

Research programme: diabetes therapy - Digital Gene Technologies

Alternative Names: diabetes therapy research programme - Digital Gene Technologies; Research programme: gene discovery - Digital Gene Technologies

Latest Information Update: 22 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Digital Gene Technologies; Harvard Medical School
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 08 Feb 2001 Collaboration between DGT and the Mayo Medical Centre to investigate the role of the ER81 transcription factor in breast and ovarian cancer
  • 05 Feb 2001 Preclinical development for Type-2 diabetes mellitus in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top